Our analysis revealed a significant correlation between EIF4A3 expression levels and immune scores in 23 out of 44 cancer types, indicating that EIF4A3 is closely associated with the tumor immune microenvironment in human cancers. Here, EIF4A3 is linked to neoplasm.